PXXLF
Price:
$0.26
Market Cap:
$11.18M
Poxel S.A., a biopharmaceutical firm in the clinical stage, is dedicated to creating innovative treatments for a range of metabolic disorders, including type 2 diabetes and various liver ailments. Its flagship product, Imeglimin, is an oral drug candidate that has successfully completed Phase III clinical trials in Japan. This promising medication is also undergoing Phase III trials in the United States and Europe for the management of type 2 diabetes. Imeglimin works by enhancing pancreatic beta cell function and mitigating insulin resistance, thereby reducing key cardiovascular and metabolic risk factors such as elevated blood lipid levels and excessive body weight. Additionally, Poxel is ...[Read more]
Industry
Biotechnology
IPO Date
2017-01-06
Stock Exchange
OTC
Ticker
PXXLF
According to Poxel S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 70.11M. This represents a change of -1.97% compared to the average of 71.52M of the last 4 quarters.
The mean historical Enterprise Value of Poxel S.A. over the last ten years is 124.73M. The current 70.11M Enterprise Value has changed 5.52% with respect to the historical average. Over the past ten years (40 quarters), PXXLF's Enterprise Value was at its highest in in the December 2019 quarter at 287.01M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.
Average
124.73M
Median
101.64M
Minimum
57.71M
Maximum
286.87M
Discovering the peaks and valleys of Poxel S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 288.21%
Maximum Annual Enterprise Value = 286.87M
Minimum Annual Increase = -59.83%
Minimum Annual Enterprise Value = 57.71M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 72.67M | 10.17% |
| 2023 | 65.96M | 14.29% |
| 2022 | 57.71M | -59.83% |
| 2021 | 143.66M | -9.36% |
| 2020 | 158.50M | -44.75% |
| 2019 | 286.87M | 288.21% |
| 2018 | 73.90M | -26.94% |
| 2017 | 101.14M | -0.98% |
| 2016 | 102.14M | -44.71% |
| 2015 | 184.72M | 52.85% |
The current Enterprise Value of Poxel S.A. (PXXLF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
65.45M
5-year avg
99.70M
10-year avg
124.73M
Poxel S.A.’s Enterprise Value is greater than Eiger BioPharmaceuticals, Inc. (28.35M), greater than Ceapro Inc. (-5906285.00), greater than Noxopharm Limited (27.81M), greater than Rapid Dose Therapeutics Corp. (20.04M), greater than Progressive Care, Inc. (7.44M), less than Titan Medical Inc. (85.61M), greater than Bionomics Limited (4.21M), greater than Living Cell Technologies Limited (21.43M), less than Sorrento Therapeutics, Inc. (111.37M), less than American Hemp Ventures, Inc. (0),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 28.35M | $12.59M | |
| -5906285.00 | $13.31M | |
| 27.81M | $14.78M | |
| 20.04M | $8.90M | |
| 7.44M | $13.49M | |
| 85.61M | $13.91M | |
| 4.21M | $8.81M | |
| 21.43M | $11.39M | |
| 111.37M | $16.54M | |
| 0 | $16.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poxel S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poxel S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Poxel S.A.'s Enterprise Value?
What is the highest Enterprise Value for Poxel S.A. (PXXLF)?
What is the 3-year average Enterprise Value for Poxel S.A. (PXXLF)?
What is the 5-year average Enterprise Value for Poxel S.A. (PXXLF)?
How does the current Enterprise Value for Poxel S.A. (PXXLF) compare to its historical average?